FTXH stock forecast, quote, news & analysis

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Bristol-Myers Squibb Co (NYSE:BMY), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), ZOETIS (NYSE:ZTS).

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq US Smart Pharmaceuticals TM Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.

The average market capitalization across the First Trust Nasdaq Pharmaceuticals ETF ETF is 57.86B. The market cap for tickers in the group ranges from 1.54B to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is ARVN at 1.54B.

The average weekly price growth across all stocks in the First Trust Nasdaq Pharmaceuticals ETF ETF was -7%. For the same ETF, the average monthly price growth was -6%, and the average quarterly price growth was 1%. BMY experienced the highest price growth at 4%, while VKTX experienced the biggest fall at -28%.

The average weekly volume growth across all stocks in the First Trust Nasdaq Pharmaceuticals ETF ETF was 78%. For the same stocks of the ETF, the average monthly volume growth was 180% and the average quarterly volume growth was 130%